Trial Profile
Effects of Perampanel on Neurophysiology Test Perimeters
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2023
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Partial epilepsies; Seizures; Tonic-clonic epilepsy
- Focus Pharmacodynamics
- 23 May 2023 Status changed from active, no longer recruiting to completed.
- 20 Dec 2021 Status changed from recruiting to active, no longer recruiting.
- 17 Aug 2021 Status changed from suspended to recruiting.